Zu-Chian Chiang | Biochemistry | Best Researcher Award | 13347

Dr. Zu-Chian Chiang | Biochemistry | Best Researcher Award 

Dr. Zu-Chian Chiang, Fujian Normal University, China

Dr. Zu-Chian Chiang is a postdoctoral fellow at the Biomedical Research Center of Southern China, Fujian Normal University, China, with a rich background in materials and chemical engineering. His research contributions span antibody-drug conjugates (ADCs), functional peptide synthesis, biomaterials for regenerative medicine, and aptamer-based cancer therapy. His work has geographic impact across Taiwan and Mainland China, contributing to translational medicine and oncology through collaborative efforts with prestigious institutions like Academia Sinica and National Taiwan University. His applied research in ADCs and biomaterial scaffolds directly supports cancer treatment innovations. Notable projects include the development of CD47-targeting ADCs for non-small cell lung cancer, and thalidomide-PD1 combinations for enhanced immunotherapy. His publications in Frontiers in Oncology, PLOS ONE, and Current Pharmaceutical Biotechnology highlight his influence in drug delivery and cancer therapeutics. In the vector control domain, his scaffold research contributes to potential localized drug delivery systems. Dr. Chiang has received awards such as the Science and Technology Commissioner honor from Quanzhou and the Biotech Elite Training Award. His achievements exemplify impactful biomedical research with real-world therapeutic implications.

Profile

Scopus

🌱 Early Academic Pursuits

Dr. Zu-Chian Chiang embarked on his scientific journey with a passion for chemistry and materials science. He earned his Master’s Degree in Chemistry from Tunghai University, Taiwan (2005–2007), under the guidance of Prof. Feng-Di Lung. Building on this solid foundation, he pursued his Ph.D. in Materials and Chemical Engineering at National United University, Taiwan (2008–2014). During his doctoral studies, he was mentored by Prof. An-Chong Chao and co-advised by Dr. Guo-Chung Dong, focusing on biomaterials and nanomedicine.

Even as a student, Dr. Chiang demonstrated exceptional academic capabilities, earning scholarships and recognition for his innovative research. His academic training laid the groundwork for his future contributions in biomedical engineering and cancer therapeutics.

🧪 Professional Endeavors

Dr. Chiang has held several prestigious postdoctoral positions. His professional journey reflects a commitment to interdisciplinary collaboration and translational research:

  • Postdoctoral Fellow at the Biomedical Research Center of Southern China, Fujian Normal University (2019–Present), working under Prof. Qi Chen.

  • Postdoctoral Fellow at the Institute of Biological Chemistry, Academia Sinica, Taiwan (2016–2019), contributing to the Taiwan Protein Project (TPP) and the Technical Support Platform Spindle Project (TSPA).

  • Postdoctoral Fellow at the Clinical Trial Center, National Taiwan University Hospital (2015–2016), supported by Taiwan’s prestigious Biotech Elite Training Program.

Throughout these roles, Dr. Chiang has engaged in cutting-edge biomedical research with direct implications for drug development and clinical applications.

🔬 Contributions and Research Focus

Dr. Chiang’s research centers on innovative therapeutic materials and drug delivery systems, particularly in cancer therapy. His core interests include:

  • Antibody-Drug Conjugates (ADCs): Targeted cancer therapies such as HER2-positive and CD47-specific ADCs.

  • Functional Peptide Synthesis for bone tissue engineering and cancer inhibition.

  • Bio-Micro-Macro Molecular Materials for regenerative medicine.

  • Aptamer Development as modulators in therapeutic settings.

Notable publications include research on CD47-targeting ADCs (Frontiers in Oncology, 2022) and HER2-positive ADCs (PLOS ONE, 2020). His work on dexamethasone-immobilized chitosan scaffolds and chitosan-caffeic acid hybrids also provides valuable insights into localized drug delivery and tissue engineering.

🏆 Accolades and Recognition

Dr. Chiang’s dedication has been acknowledged through numerous awards:

  • 🥇 Science and Technology Commissioner, Quanzhou, Fujian Province (2020)

  • 🥇 Biotech Elite Training Award, National Taiwan University & Ministry of Science and Technology (2016)

  • 🥇 Chung Hwa Rotary Doctoral Program Award, Taiwan (2012)

  • 🥇 Outstanding Doctoral Scholarship, National United University (2010)

  • 🥇 Master’s Program Scholarship, Hunan Fellow Association of Taiwan (2007)

  • 🥇 Rotary Leadership Award, Miaoli Southeastern Xindong Satellite Rotary Club (2017)

These accolades affirm his position as a respected figure in the fields of biomedical chemistry and translational medicine.

🌍 Impact and Influence

Dr. Chiang’s work has made a geographic impact spanning Taiwan and Mainland China. His collaborative research in academia and clinical centers bridges the gap between laboratory research and therapeutic application. He actively contributes as a peer reviewer for the International Journal of Biological Macromolecules, influencing scientific standards and publication quality globally.

He is also engaged in community service through leadership in Rotary International, fostering science-driven community development and education.

🌟 Legacy and Future Contributions

Dr. Chiang’s legacy is being built on the foundation of scientific excellence, mentorship, and translational impact. His research not only pushes the boundaries of biomedical engineering but also aims to enhance the effectiveness of cancer treatments in clinical practice. With a commitment to developing next-generation targeted therapies and biomaterial scaffolds, Dr. Chiang is poised to shape the future of personalized medicine and regenerative technologies.

Looking ahead, he aims to establish interdisciplinary collaborations and contribute to global health initiatives, making life-saving therapies more effective and accessible.

Publication Top Notes

Development of Novel CD47-Specifific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo. 

Author: Z.C., Chiang, Zu Chian, S., Fang, Shubin, Y., Shen, Yangkun, J., Lin, Jizhen, Q., Chen, Qi

Journal: Frontiers in Oncology,

Year: 2022

Preparation and characterization of dexamethasone-immobilized chitosan scaffold

Author: Z.C., Chiang, Zu Chian, S., Yu, Shuhuei, A., Chao, Anchong, G.C., Dong, Guo Chung

Journal: Journal of Bioscience and Bioengineering, 

Year: 2012

 

Obinna Chukwuemeka | Biochemistry | Best Researcher Award |13170

Dr. Obinna Chukwuemeka | Biochemistry | Best Researcher Award 

Dr. Obinna Chukwuemeka, University of Calabar, Nigeria

Dr. Obinna Chukwuemeka is a distinguished scholar affiliated with the University of Calabar, Nigeria. His academic and research contributions focus on advancing knowledge in his field, fostering innovation, and addressing critical challenges in his area of expertise. As an educator and researcher, Dr. Chukwuemeka is dedicated to promoting academic excellence and sustainable development through impactful studies and mentorship.

Profile

Google Scholar

Scopus

Educational Qualification 📚

Dr. Obinna Chukwuemeka Godfrey embarked on his academic journey with a strong passion for biochemistry. He earned his BSc in Biochemistry with second-class honors from Michael Okpara University of Agriculture, Umudike, Nigeria. Building on this foundation, he pursued his MSc in Biochemistry, graduating with distinction from the same institution. His academic excellence and research prowess led him to pursue his PhD in Biochemistry, which he also completed with distinction.

Professional Endeavors 💼

Dr. Godfrey’s professional endeavors began as a Quality Assurance Officer/Lab Technician (Contract) at Guinness Nigeria PLC Aba Brewery, where he worked from 2014 to 2019. He then transitioned to academia, becoming a Lecturer 1 at the Department of Biochemistry, University of Calabar, Nigeria. Additionally, he served as a Visiting Lecturer at the Department of Biochemistry, Clifford University, Owerrinta, Abia State, Nigeria, in 2020.

Contributions and Research Focus 🔬

Dr. Godfrey’s research focus lies at the intersection of biochemistry, medicinal chemistry, and computational biology. He has made significant contributions to the understanding of the therapeutic properties of various compounds, including biflavonoids, Schiff base derivatives, and terpolymers. His research has explored the potential of these compounds in combating diseases such as malaria, urinary tract infections, and cancer.

Accolades and Recognition 🏆

Dr. Godfrey’s academic and research achievements have earned him recognition and accolades. He is a member of the Biochemical Society, London, the American Society for Biochemistry and Molecular Biology (ASBMB), and the Nigerian Society of Biochemistry and Molecular Biology (NSBMB). His research has been published in reputable international journals, including the Journal of Molecular Structure, Zeitschrift für Physikalische Chemie, and the Journal of the Indian Chemical Society.

Impact and Influence 🌐

Dr. Godfrey’s research has contributed significantly to the understanding of the therapeutic properties of various compounds. His work has the potential to inform the development of new drugs and therapies for diseases such as malaria, urinary tract infections, and cancer. His research has also been recognized internationally, with collaborations and citations from researchers around the world.

Legacy and Future Contributions 🔜

As a rising star in the field of biochemistry and medicinal chemistry, Dr. Godfrey’s future contributions are eagerly anticipated. His ongoing research projects, including the investigation of the therapeutic properties of various compounds, hold promise for breakthroughs in the treatment and prevention of diseases. His commitment to mentoring and teaching the next generation of researchers ensures that his legacy will continue to inspire and shape the field for years to come.

Publication Top Notes

Structural analysis, reactivity descriptors (HOMO-LUMO, ELF, NBO), effect of polar (DMSO, EtOH, H2O) solvation, and libido-enhancing potential of resveratrol by molecular docking

Author: EA Adindu, OC Godfrey, EI Agwupuye, BO Ekpong, DC Agurokpon, …
Journal: Chemical Physics Impact
Year: 2023
Author: CB Ubah, N Mujafarkani, A Sundaravadivelu, N Narendran, OC Godfrey, …
Journal: Molecular Structure
Year: 2024

Metals (Ga, In) encapsulated aluminum nitride nanotubes (AlNNTs) as nonenzymatic sensors for biomarker volatiles of liver cirrhosis: A computational study

Author: OC Godfrey, H Louis, AG Al-Sehemi, TE Gber, YN Kavil, OF Ede, FO Akor, …
Journal: Molecular Liquids
Year: 2023

Hexachlorobenzene (HCB) adsorption onto the surfaces of C60, C59Si, and C59Ge: Insight from DFT, QTAIM, and NCI

Author: OCG Mohsen D. Mohammadi, Hewa Y. Abdullah, Hitler Louis, Emmanuel E. Etim …
Journal: Chemical Physics Impact
Year: 2023